Onconetix Share Price

Onconetix Share Price

NASDAQ: ONCO | Micro Cap | Healthcare
$2.86
-$0.29 (-9.21%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Onconetix Stock Performance

Open
$2.93
Prev. Close
$3.15
Circuit Range
N/A
Day Range
$2.93 - $2.93
Year Range
$0.09 - $7.72
Volume
167
Average Traded
$2.93

Onconetix Share Price Today

As of 22 November 2026, Onconetix, Inc.'s share price is $2.86. The stock opened at $2.93, compared to its previous close of $3.15. During today's trading session, Onconetix, Inc.'s share price traded between $2.93 and $2.93, with an average price of $2.93. Over the past 52 weeks, the stock has recorded a high of $7.72 and a low of $0.09. In terms of performance, Onconetix, Inc.'s share price has risen by 137.34% over the last six months and is up 4.57% on a year-on-year basis.

Onconetix Share Price Chart

Line chart of the Onconetix price trend over the selected period. The price fell overall, ranging from 2.86 to 2.93, ending at 2.86.
$2.93$2.93
L
Show Current Price
H

Onconetix Stock Fundamentals & Key Indicators

Market Cap
$2.68M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-40.26
Revenue (TTM)
$820.00M
Return On Equity (TTM)
191.09%
Profit Margin
-1893.90%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-657.85%

Onconetix Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.30$0.02$0.02$0.10
Net Profit$5.67-$4.21-$2.87-$31.63
Net Profit Margin1890.00%-21050.00%-14350.00%-31630.00%
Income ChangeN/A-174.25%31.83%-1002.09%

Onconetix Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.06$2.52$0.82
Net Profit-$37.41-$58.90-$15.53
Net Profit Margin-62350.00%-2337.30%-1893.90%
Income ChangeN/A-57.44%73.63%

Onconetix Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets18.8627.2381.68
Current Assets6.070.955.84
Total Assets24.9328.1887.52
Non Current Liabilities0.020.284.69
Current Liabilities9.1418.2917.19
Total Liabilities9.1618.5721.88
Shareholders' Equity15.768.541.4

Onconetix Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-9.68-10.5-13.58
Investing0.0-0.03-8.65
Financing14.456.741.04

Corporate Actions

Split
Ex-date: 06 Nov 2026

Split
Ex-date: 21 May 2026

Split
Ex-date: 25 Mar 2026

Split
Ex-date: 13 Jun 2025

Split
Ex-date: 24 Sep 2024

About Onconetix

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.

Onconetix Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.51
$2.93
+436.63%
Oct 2026
$0.77
$0.55
-29.73%
Sep 2026
$0.72
$0.78
+21.79%
Aug 2026
$0.80
$0.64
-15.61%
Jul 2026
$1.04
$0.76
-34.83%
Jun 2026
$1.18
$1.16
-3.73%
May 2026
$0.66
$1.21
+75.40%
Apr 2026
$1.46
$0.69
-54.05%
Mar 2026
$0.65
$1.50
+126.52%
Feb 2026
$1.39
$0.66
-55.41%
Jan 2026
$1.69
$1.48
-7.50%
Dec 2025
$2.70
$1.60
-41.50%

Onconetix Share Price FAQs